Single versus combination intravenous anti‐pseudomonal antibiotic therapy for people with cystic fibrosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Single Versus Combination Intravenous Anti‐pseudomonal Antibiotic Therapy for People With Cystic Fibrosis." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433655/all/images/tooltip-triangle.png. Accessed 28 April 2024.
Single versus combination intravenous anti‐pseudomonal antibiotic therapy for people with cystic fibrosis. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433655/all/images/tooltip-triangle.png. Accessed April 28, 2024.
Single versus combination intravenous anti‐pseudomonal antibiotic therapy for people with cystic fibrosis. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433655/all/images/tooltip-triangle.png
Single Versus Combination Intravenous Anti‐pseudomonal Antibiotic Therapy for People With Cystic Fibrosis [Internet]. In: Cochrane Abstracts. [cited 2024 April 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433655/all/images/tooltip-triangle.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Single versus combination intravenous anti‐pseudomonal antibiotic therapy for people with cystic fibrosis
ID - 433655
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433655/all/images/tooltip-triangle.png
DB - Evidence Central
DP - Unbound Medicine
ER -